Prise en charge des consequences de la carence oestrogenique apres cancer du sein.

Antineoplastic Agents/adverse effects; Breast Neoplasms/therapy; Estradiol/deficiency; Female; Humans; Menopause; Osteoporosis/etiology/prevention & control; Quality of Life

Abstract :

[en] The prevention and the treatment of oestrogen deficiency induced by breast cancer treatments are crucial in the management of patients. The impacts of this deficiency must not be neglected: quality of life impairments inducing eventually premature withdrawal of hormonotherapies, and excess of bone and cardio-vascular morbidities and mortalities, especially in good prognosis young women. Management strategies of short and long term effects of this deficiency are reviewed and discussed here.

Disciplines :

Reproductive medicine (gynecology, andrology, obstetrics)

Author, co-author :

BLERET, Valerie ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

PINTIAUX, Axelle ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR

BELIARD, Aude ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR

Kridelka, Frédéric ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie et obstétrique

LIFRANGE, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

Van Cauwenberge, Jean-Rémy ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique-Sénologie

DESREUX, Joëlle ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie

Language :

French

Title :

Prise en charge des consequences de la carence oestrogenique apres cancer du sein.

Alternative titles :

[en] Management of estrogen deficiency after breast cancer

Publication date :

2011

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

5-6

Pages :

385-92

Peer reviewed :

Peer reviewed

Available on ORBi :

since 19 March 2012

Statistics

Number of views

295 (15 by ULiège)

Number of downloads

1327 (8 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Hershman, D.L., Kushi, L.H., Shao, T., I. Early discontinuation and non adherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients (2010) Neugut J Clin Oncol, 28, pp. 4120-4128
Leining, M.G., Gelber, S., Rosenberg, R., Menopausal-type symptoms in young breast cancer survivors (2010) Ann Oncol, 21, pp. 983-987
Mar Fan, H.G., Houédé-Tchen, N., Chemerynsky, I., Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: A prospective controlled study (2010) Oncol, 21, pp. 983-987
Kenemans, P., J Bundred, N., Foidart, J.M., Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: A double-blind, randomised, non-inferiority trial (2009) Lancet Oncol, 10, pp. 135-146
Goodwin, J.W., Green, S.J., Moinpour, C.M., Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626 (2010) J Clin Oncol, 28, pp. 5147-5152
Aguirre, W., Chedraui, P., Mendoza, J., Ruilova, I., Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes (2010) Gynecol Endocrinol, 26, pp. 333-337
Buijs, C., Mom, C.H., Willemse, P.H., Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: A double-blind, randomized cross-over study (2009) Breast Cancer Res Treat, 115, pp. 573-580
Bordeleau, L., Pritchard, K.I., Loprinzi, C.L., Ennis, M., Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors (2010) Gynecol Endocrinol, 26, pp. 333-337
Duijts, S.F., Oldenburg, H.S., Van Beurden, M., Aaronson, N.K., Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: Design of a multicenter trial (2009) Support Care Cancer, 17, pp. 1301-1309
Huang, A.J., Subak, L.L., Wing, R., An intensive behavioral weight loss intervention and hot flushes in women (2010) Arch Intern Med, 170, pp. 1161-1167. , Program to Reduce Incontinence by Diet and Exercise Investigators
Carson, J.W., Carson, K.M., Porter, L.S., Yoga of Awareness program for menopausal symptoms in breast cancer survivors: Results from a randomized trial (2009) Pharmacology, 84, pp. 68-73
Cheema, D., Coomarasamy, A., El-Toukhy, T., Non-hormonal therapy of post-menopausal vasomotor symptoms: A structured evidence-based review (2007) Archives of Gynecology and Obstetrics, 276 (5), pp. 463-469. , DOI 10.1007/s00404-007-0390-9
Rajah, T.T., Du, N., Drews, N., Cohn, R., Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells (2010) Pharmacol, 84, pp. 68-73
Kang, X., Zhang, Q., Wang, S., Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy (2010) CMAJ, 182, pp. 1857-1862
Rostock, M., Fischer, J., Mumm, A., Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - A prospective observational study (2011) Gynecol Endocrinol, , janv 13 (Epub ahead of print)
Fobair, P., Spiegel, D., Concerns about sexuality after breast cancer (2009) Cancer J, 15, pp. 19-26
Baum, M., Cassileth, B.R., Daniel, R., Ernst, E., Filshie, J., Nagel, G.A., Horneber, M., Smith, W.B., The role of complementary and alternative medicine in the management of early breast cancer: Recommendations of the European Society of Mastology (EUSOMA) (2006) European Journal of Cancer, 42 (12), pp. 1711-1714. , DOI 10.1016/j.ejca.2006.02.019, PII S095980490600342X
Davis, S.A., Moreau, M., Kroll, R., Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen (2008) N Engl J Med, 359, pp. 2005-2017
Kaaks, R., Rinaldi, S., Key, T.J., Berrinno, F., Peeters, P.H.M., Biessy, C., Dossus, L., Riboli, E., Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition (2005) Endocrine-Related Cancer, 12 (4), pp. 1071-1082. , DOI 10.1677/erc.1.01038
Labrie, F., Archer, D.F., Bouchard, C., Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia (2011) Climacteric, 14, pp. 282-288
Crew, K.D., Greenlee, H., Capodice, J., Raptis, G., Brafman, L., Fuentes, D., Sierra, A., Hershman, D.L., Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer (2007) Journal of Clinical Oncology, 25 (25), pp. 3877-3883. , DOI 10.1200/JCO.2007.10.7573
Magliano, M., Menopausal arthralgia: Fact or fiction (2010) Maturitas, 67, pp. 29-33
Sehdev, S., Martin, G., Sideris, L., Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer (2009) Current Oncol, 16, pp. S14-S23
Khan, Q.J., Reddy, P.S., Kimler, B.F., Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer (2010) Breast Cancer Res Treat, 119, pp. 111-118
Nichols, H.B., Trentham-Dietz, A., Egan, K.M., Body mass index before and after breast can cer diagnosis: Associations with all-cause, breast cancer, and cardiovascular disease mortality (2009) Cancer Epidemiol Biomarkers Prev, 18, pp. 1403-1409
Eliassen, A.H., Hankinson, S.E., Rosner, B., Physical activity and risk of breast cancer among postmenopausal women (2010) Arch Intern Med, 170, pp. 1758-1764
Holick, C.N., Newcomb, P.A., Trentham-Dietz, A., Titus-Ernstoff, L., Bersch, A.J., Stampfer, M.J., Baron, J.A., Willett, W.C., Physical activity and survival after diagnosis of invasive breast cancer (2008) Cancer Epidemiology Biomarkers and Prevention, 17 (2), pp. 379-386. , http://cebp.aacrjournals.org/cgi/reprint/17/2/379, DOI 10.1158/1055-9965.EPI-07-0771
Hermelink, K., Henschel, V., Untch, M., Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: Results of a multicenter, prospective, longitudinal study (2008) Cancer, 113, pp. 2431-2439
Kaufmann, M., Jonat, W., Blamey, R., Cuzick, J., Namer, M., Fogelman, I., De Haes, J.C., Sauerbrei, W., Survival analyses from the ZEBRA study: Goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer (2003) European Journal of Cancer, 39 (12), pp. 1711-1717. , DOI 10.1016/S0959-8049(03)00392-7
Gnant, M., Mlineritsch, B., Luschin-Ebengreuth, G., Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-Year follow-up of the ABCSG-12 bone-mineral density substudy (2008) Lancet Oncol, 9, pp. 840-849. , Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Brufsky, A., Bundred, N., Coleman, R., Lambert-Falls, R., Mena, R., Hadji, P., Jin, L., Perez, E.A., Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole (2008) Oncologist, 13 (5), pp. 503-514. , http://theoncologist.alphamedpress.org/cgi/reprint/13/5/503, DOI 10.1634/theoncologist.2007-0206
Green, J., Czanner, G., Reeves, G., Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: Case-control analysis within a UK primary care cohort (2010) BMJ, 341, pp. c4444
Reid, D.M., Prevention of osteoporosis after breast cancer (2009) Maturitas, 64, pp. 4-8
Ellis, G.K., Bone, H.G., Chlebowski, R., Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer (2008) J Clin Oncol, 26, pp. 4875-4882
Rivera, C.M., Grossardt, B.R., Rhodes, D.J., Increased cardiovascular mortality after early bilateral oophorectomy (2009) Menopause, 16, pp. 15-23
Rocca, W.A., Shuster, L.T., Grossardt, B.R., Long-term effects of bilateral oophorectomy on brain aging: Unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging (2009) Women's Health, 5, pp. 39-48
Rocca, W.A., Bower, J.H., Maraganore, D.M., Increased risk of parkinsonism in women who underwent oophorectomy before menopause (2008) Neurology, 70, pp. 200-209
Gardner, F.J., Konje, J.C., Abrams, K.R., Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: A randomised controlled trial (2000) Lancet, 356, pp. 1711-1717
Bleret, V., Desreux, J., Cusumano, P., Prévention primaire et secondaire chez les femmes à haut risque de cancer mammaire (2011) Rev Med Liège, 66, pp. 245-249
Loibl, S., Lintermans, A., Dieudonné, A.S., Neven, P., Management of menopausal symptoms in breast cancer patients (2011) Maturitas, 68, pp. 148-154